• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Indivior PLC (INDV)

ORD USD0.50
Sell: 851.00p|Buy: 853.00p|Change: 7.50 (-0.87%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment

Company profile

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Address

234 Bath Road
Slough
Berkshire
GBR
SL1 4EE

Telephone

+44 1753217800

Website

https://www.indivior.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Indivior PLC First Quarter Earnings Conference Call for 20262026-04-24T08:00:00
Indivior PLC First Quarter Earnings Results for 20262026-04-24T02:00:00
Indivior PLC Annual Report for 20252026-03-03T00:00:00
Indivior PLC Fourth Quarter Earnings Conference Call for 20252026-02-20T08:00:00
Indivior PLC Fourth Quarter Earnings Results for 20252026-02-20T02:00:00
Indivior PLC Third Quarter Earnings Conference Call for 20252025-10-24T13:00:00
Indivior PLC Third Quarter Earnings Results for 20252025-10-24T07:00:00
Indivior PLC Second Quarter Earnings Conference Call for 20252025-07-25T13:00:00
Indivior PLC Second Quarter Earnings Results for 20252025-07-25T07:00:00
Indivior PLC Annual General Meeting for 20252025-05-08T12:00:00
Indivior PLC First Quarter Earnings Conference Call for 20252025-04-24T08:00:00
Indivior PLC First Quarter Earnings Results for 20252025-04-24T02:00:00

Previous key dates

NameKey Date
Indivior PLC First Quarter Earnings Conference Call for 20252025-04-24T08:00:00
Indivior PLC First Quarter Earnings Results for 20252025-04-24T02:00:00
Indivior PLC Annual Report for 20242025-03-03T00:00:00
Indivior PLC Fourth Quarter Earnings Conference Call for 20242025-02-20T08:00:00
Indivior PLC Fourth Quarter Earnings Results for 20242025-02-20T02:00:00
Piper Sandler 36th Annual Healthcare Conference2024-12-03T10:00:00
Indivior PLC Third Quarter Earnings Conference Call for 20242024-10-24T13:00:00
Indivior PLC Third Quarter Earnings Results for 20242024-10-24T07:00:00
Indivior PLC Second Quarter Earnings Conference Call for 20242024-07-25T13:00:00
Indivior PLC Second Quarter Earnings Results for 20242024-07-25T07:00:00
Indivior Business Update2024-07-09T08:00:00
Jefferies Global Healthcare Conference - New York City, NY2024-06-05T08:30:00
Indivior PLC Annual General Meeting for 20242024-05-09T12:00:00
Indivior PLC First Quarter Earnings Conference Call for 20242024-04-25T13:00:00
Indivior PLC First Quarter Earnings Result for 20242024-04-25T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.